Clinical trial
Mesenchymal Stem Cell Therapy for Liver Cirrhosis: A Phase I/II Study
NCT03626090 is registered in ClinicalTrials.gov with Stem Med Pte. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mesenchymal Stem Cell Therapy for Liver Cirrhosis: A Phase I/II Study
- Lead sponsor
- Stem Med Pte. Ltd.
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- August 18, 2018
- Completion date
- October 22, 2021
- Enrollment
- 20 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.